Published in Medical Letter on the CDC and FDA, December 28th, 2003
Ethicon received clearance from the U.S. Food and Drug Administration (FDA) to expand the use of its Mammotome Breast Biopsy System so doctors can now use it for management of fibroadenomas (palpable non-cancerous breast lumps), a condition common among young women in their late teens, twenties and thirties. The Mammotome System has already been used for more than 1.7 million breast biopsies since 1995.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA